Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities

References

• Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and global analysis. Eur Respir J. 2006;28(3):523–532. doi:10.1183/09031936.06.0012460516611654
   PubMed Web of Science ®Google Scholar
• GOLD. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD);2019 [Update 2019] Available from: http://goldcopd.org. Accessed February 5, 2019
   Google Scholar
• GOLD. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010; 2010 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed March 22, 2011.
   Google Scholar
• Fotheringham I, Meakin G, Punekar YS, Riley JH, Cockle SM, Singh SJ. Comparison of laboratory- and field-based exercise tests for COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2015;10:625–643. doi:10.2147/COPD.S7051825834421
   PubMed Web of Science ®Google Scholar
• Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–1478. doi:10.1183/09031936.0015041425359356
   PubMed Web of Science ®Google Scholar
• Cote CG, Casanova C, Marin JM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008;31(3):571–578. doi:10.1183/09031936.0010450717989117
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• Andrianopoulos V, Wouters EF, Pinto-Plata VM, et al. Prognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE study. Respir Med. 2015;109(9):1138–1146. doi:10.1016/j.rmed.2015.06.01326143282
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Iattoni A, Venturelli E, et al. Predicting walking-induced oxygen desaturations in COPD patients: a statistical model. Respir Care. 2013;58(9):1495–1503. doi:10.4187/respcare.0232123362168
   PubMed Web of Science ®Google Scholar
• Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010;104(6):849–857. doi:10.1016/j.rmed.2009.12.00720471236
   PubMed Web of Science ®Google Scholar
• Celli B, Tetzlaff K, Criner G, et al. The 6 min-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification Consortium. Am J Respir Crit Care Med. 2016;194(12):1483–1493. doi:10.1164/rccm.201508-1653OC27332504
   PubMed Web of Science ®Google Scholar
• Casanova C, Aguirre-Jaime A, de Torres JP, et al. Longitudinal assessment in COPD patients: multidimensional variability and outcomes. Eur Respir J. 2014;43(3):745–753. doi:10.1183/09031936.0009691324072210
   PubMed Web of Science ®Google Scholar
• Waatevik M, Johannessen A, Gomez Real F, et al. Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. Eur Respir J. 2016;48(1):82–91. doi:10.1183/13993003.00975-201527076586
   PubMed Web of Science ®Google Scholar
• Andrianopoulos V, Franssen FM, Peeters JP, et al. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol. 2014;190:40–46. doi:10.1016/j.resp.2013.10.00224121092
   PubMed Web of Science ®Google Scholar
• Andrianopoulos V, Celli BR, Franssen FM, et al. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: results from the ECLIPSE study. Respir Med. 2016;119:87–95. doi:10.1016/j.rmed.2016.08.02327692154
   PubMed Web of Science ®Google Scholar
• Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391–398.6776858
   PubMed Web of Science ®Google Scholar
• Takigawa N, Tada A, Soda R, et al. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med. 2007;101(3):561–567. doi:10.1016/j.rmed.2006.06.01716899358
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31:204–212. doi:10.1183/09031936.0011430718166598
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD current understanding, unanswered questions, and research needs. Chest. 2008;134(4):43S–56S. doi:10.1378/chest.08-034218842932
   PubMed Web of Science ®Google Scholar
• Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009;135(4):975–982. doi:10.1378/chest.08-206219017866
   PubMed Web of Science ®Google Scholar
• Perez T, Burgel PR, Paillasseur JL, et al. Modified medical research council scale vs Baseline Dyspnea index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1663–1672. doi:10.2147/COPD.S8240826316740
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. doi:10.1164/rccm.200703-456SO17507545
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.10377201
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George‘s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.6880820
   PubMed Web of Science ®Google Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374(9691):704–711. doi:10.1016/S0140-6736(09)61301-519716962
   PubMed Web of Science ®Google Scholar
• Watz H, Pitta F, Rochester CL, et al. An official European respiratory society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi:10.1183/09031936.0004681425359358
   PubMed Web of Science ®Google Scholar
• Mahler DA, Ward J, Waterman LA, Baird JCD. Longitudinal changes in patient-reported Dyspnea in patients with COPD. COPD. 2012;9:522–527. doi:10.3109/15412555.2012.70167822876883
   PubMedGoogle Scholar
• Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697–709. doi:10.2147/COPD.S3267523093901
   PubMed Web of Science ®Google Scholar
• Waatevik M, Johannessen A, Hardie JA, et al. Different COPD disease characteristics are related to different outcomes in the 6 min walk test. COPD. 2012;9(3):227–234. doi:10.3109/15412555.2011.65024022497532
   PubMedGoogle Scholar
• Spruit MA, Polkey MI, Celli B, et al. Predicting outcomes from 6 min walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012;13(3):291–297. doi:10.1016/j.jamda.2011.06.00921778120
   PubMed Web of Science ®Google Scholar
• Mesquita R, Franssen FM, Houben-Wilke S, et al. What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders? Int J Cardiol. 2016;225:365–370. doi:10.1016/j.ijcard.2016.10.01627760413
   PubMed Web of Science ®Google Scholar
• Oliveira MF, Arbex FF, Alencar MC, et al. Heart failure impairs muscle blood flow and endurance exercise tolerance in COPD. COPD 2016;13(4):407–415. doi:10.3109/15412555.2015.1117435
   Google Scholar
• McNamara RJ, Houben-Wilke S, Franssen FME, et al. Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease. Respir Med. 2018;138:81–87. doi:10.1016/j.rmed.2018.03.03229724398
   PubMed Web of Science ®Google Scholar
• Houben-Wilke S, Jorres RA, Bals R, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and systemic consequences-comorbidities network study. Am J Respir Crit Care Med. 2017;195(2):189–197. doi:10.1164/rccm.201602-0354OC27532739
   PubMed Web of Science ®Google Scholar
• Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi:10.1183/09031936.0015031425359355
   PubMed Web of Science ®Google Scholar
• Golpe R, Perez-de-Llano LA, Mendez-Marote L, Veres-Racamonde A. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6 min walk test in COPD patients. Respir Care. 2013;58(8):1329–1334. doi:10.4187/respcare.0229023322886
   PubMed Web of Science ®Google Scholar
• Casanova C, Cote C, Marin JM, et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008;134(4):746–752. doi:10.1378/chest.08-052018625667
   PubMed Web of Science ®Google Scholar
• Ora J, Laveneziana P, Wadell K, Preston M, Webb KA, O’Donnell DE. Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol. 2011;111(1):10–19. doi:10.1152/japplphysiol.01131.201021350021
   PubMed Web of Science ®Google Scholar
• Guenette JA, Webb KA, O’Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J. 2012;40(2):322–329. doi:10.1183/09031936.0015771122183485
   PubMed Web of Science ®Google Scholar